|
Jun 24
|
Verona Pharma price target raised to $160 from $76 at Piper Sandler
|
|
Jun 24
|
Up 515%, Watch This Biopharma Breakout
|
|
Jun 13
|
Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch
|
|
May 21
|
Verona Pharma Announces June 2025 Investor Conference Participation
|
|
May 8
|
What Makes Verona Pharma plc (VRNA) a Good Investment?
|
|
May 6
|
IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout
|
|
May 6
|
Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025
|
|
Apr 17
|
Ritedose to double single-vial packaging capabilities with seventh Syntegon line
|
|
Apr 15
|
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
|
|
Mar 14
|
Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?
|
|
Mar 3
|
Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus
|
|
Mar 2
|
Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
|
|
Feb 28
|
Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...
|
|
Feb 27
|
Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
|
|
Feb 23
|
Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025?
|
|
Feb 18
|
Verona Pharma Announces March 2025 Investor Conference Participation
|
|
Feb 13
|
Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update
|
|
Feb 12
|
What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'
|
|
Oct 9
|
Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why
|
|
Aug 3
|
Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability
|